Serena Williams has shocked the advertising world — not by winning another Grand Slam, but by becoming the face of GLP-1 weight-loss drugs. Partnering with telehealth company Ro, Williams is starring in TV, billboard, and online campaigns to promote medications like Ozempic and Wegovy.
In this episode, I break down:

• Why Serena’s endorsement marks a turning point in the celebrity era of weight-loss drug ads.

• How she credits GLP-1s with helping her lose 31 pounds after having children.

• Why her involvement is sparking debate — from body-positivity advocates to politicians questioning the safety messaging.

• The strategy behind Ro’s pivot from faceless ads to cultural icons, and how this challenges stereotypes about who these drugs are “for.”

• What this shift says about celebrity influence, health marketing, and America’s complicated relationship with body image.

Love her or not, Serena’s move into the weight-loss conversation is bigger than one endorsement — it’s a signal that this debate is about to go mainstream.
If you ever want to buy or sell a property anywhere in the world, our team would be honored to help get you to your next destination.
Until next time, stay curious, stay hungry, and as always… stay ALL IN!
Amit Bhuta
COMPASS
ALL IN Miami Group
Licensed Real Estate Agent
(305) 439-3031 Mobile
[email protected]
ALLinMiami.com.